近视防治方法的研究进展
Research Advances in Methods for the Prevention and Control of Myopia
DOI: 10.12677/acm.2025.1541266, PDF,   
作者: 朱思颖, 高 仪, 蔡贤祺, 田 东：云南中医药大学第二临床学院，云南 昆明；熊光轶*：云南中医药大学基础医学院，云南 昆明
关键词: 近视；治疗方法；个性化近视管理；综述；Myopia； Therapies； Personalized Myopia Management； Review
摘要: 随着全球近视率的迅速上升，近视已成为重大的公共健康问题。本文通过查阅近年来相关文献，从光学干预、药物治疗、手术和激光疗法、未来潜在的治疗方法等方面综述近视治疗的现状及最新进展，为不同近视人群治疗方案的选择提供参考。并提出未来应加强多学科合作，结合人工智能等新兴技术，开发个性化近视管理方案，为近视防控提供新思路，以期实现更有效的近视管理。
Abstract: With the rapid increase in global myopia rates, myopia has become a major public health issue. This article reviews the current status and latest progress in myopia treatment by consulting relevant literature in recent years, covering aspects such as optical intervention, drug therapy, surgical and laser therapy, and potential future treatment methods. It aims to provide references for the selection of treatment plans for different myopia populations. Moreover, it proposes that in the future, interdisciplinary cooperation should be strengthened, and emerging technologies such as artificial intelligence should be combined to develop personalized myopia management plans, providing new ideas for myopia prevention and control, with the goal of achieving more effective myopia management.
文章引用：朱思颖, 高仪, 蔡贤祺, 田东, 熊光轶. 近视防治方法的研究进展[J]. 临床医学进展, 2025, 15(4): 3010-3016. https://doi.org/10.12677/acm.2025.1541266

参考文献

[1] Holden, B.A., Fricke, T.R., Wilson, D.A., Jong, M., Naidoo, K.S., Sankaridurg, P., et al. (2016) Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology, 123, 1036-1042. [Google Scholar] [CrossRef] [PubMed]
[2] Shi, H., Guo, N., Zhao, Z., He, X., Li, J. and Duan, J. (2023) Global Prevalence of Myopic Macular Degeneration in General Population and Patients with High Myopia: A Systematic Review and Meta-Analysis. European Journal of Ophthalmology, 34, 631-640. [Google Scholar] [CrossRef] [PubMed]
[3] Corpus, G., Molina-Martin, A. and Piñero, D.P. (2023) Efficacy of Soft Contact Lenses for Myopia Control: A Systematic Review. Seminars in Ophthalmology, 39, 185-192. [Google Scholar] [CrossRef] [PubMed]
[4] Parker, K.E. and Leach, N.E. (2016) Orthokeratology: An Academic Perspective. Eye & Contact Lens: Science & Clinical Practice, 42, 56-60. [Google Scholar] [CrossRef] [PubMed]
[5] Sankaridurg, P., Bakaraju, R.C., Naduvilath, T., Chen, X., Weng, R., Tilia, D., et al. (2019) Myopia Control with Novel Central and Peripheral Plus Contact Lenses and Extended Depth of Focus Contact Lenses: 2 Year Results from a Randomised Clinical Trial. Ophthalmic and Physiological Optics, 39, 294-307. [Google Scholar] [CrossRef] [PubMed]
[6] Yam, J.C., Zhang, X.J., Zhang, Y., Yip, B.H.K., Tang, F., Wong, E.S., et al. (2023) Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA, 329, 472-481. [Google Scholar] [CrossRef] [PubMed]
[7] Yam, J.C., Jiang, Y., Tang, S.M., Law, A.K.P., Chan, J.J., Wong, E., et al. (2019) Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 126, 113-124. [Google Scholar] [CrossRef] [PubMed]
[8] Yam, J.C., Li, F.F., Zhang, X., Tang, S.M., Yip, B.H.K., Kam, K.W., et al. (2020) Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology, 127, 910-919. [Google Scholar] [CrossRef] [PubMed]
[9] Brown, D.M., Yu, J., Kumar, P., Paulus, Q.M., Kowalski, M.A., Patel, J.M., et al. (2023) Exogenous All-Trans Retinoic Acid Induces Myopia and Alters Scleral Biomechanics in Mice. Investigative Opthalmology & Visual Science, 64, Article 22. [Google Scholar] [CrossRef] [PubMed]
[10] Singh, H., Singh, H., Sharma, S., Kaur, H., Kaur, A., Kaur, S., et al. (2023) Genotoxic and Mutagenic Potential of 7-Methylxanthine: An Investigational Drug Molecule for the Treatment of Myopia. Drug and Chemical Toxicology, 47, 264-273. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, X., Pardue, M.T., Iuvone, P.M. and Qu, J. (2017) Dopamine Signaling and Myopia Development: What Are the Key Challenges. Progress in Retinal and Eye Research, 61, 60-71. [Google Scholar] [CrossRef] [PubMed]
[12] Frederikse, P.H. and Kasinathan, C. (2015) Lens GABA Receptors Are a Target of Gaba-Related Agonists That Mitigate Experimental Myopia. Medical Hypotheses, 84, 589-592. [Google Scholar] [CrossRef] [PubMed]
[13] Sánchez‐Tena, M.Á., Ballesteros‐Sánchez, A., Martinez‐Perez, C., Alvarez‐Peregrina, C., De‐Hita‐Cantalejo, C., Sánchez‐González, M.C., et al. (2024) Assessing the Rebound Phenomenon in Different Myopia Control Treatments: A Systematic Review. Ophthalmic and Physiological Optics, 44, 270-279. [Google Scholar] [CrossRef] [PubMed]
[14] Pidro, A., Biscevic, A., Pjano, M., Mravicic, I., Bejdic, N. and Bohac, M. (2019) Excimer Lasers in Refractive Surgery. Acta Informatica Medica, 27, 278-283. [Google Scholar] [CrossRef] [PubMed]
[15] Kirmaci Kabakci, A., Kepez Yildiz, B., Yildirim, Y., Agca, A., Ondes Yilmaz, F., Demir, G., et al. (2020) Refractive and Visual Outcomes of Small Incision Lenticule Extraction (SMILE) in Eyes with Thin Corneas. Eye, 35, 2302-2309. [Google Scholar] [CrossRef] [PubMed]
[16] Gulmez, M., Tekce, A. and Kamıs, U. (2020) Comparison of Refractive Outcomes and High-Order Aberrations after Small Incision Lenticule Extraction and Wavefront-Guided Femtosecond-Assisted Laser in Situ Keratomileusis for Correcting High Myopia and Myopic Astigmatism. International Ophthalmology, 40, 3481-3489. [Google Scholar] [CrossRef] [PubMed]
[17] Way, C., Elghobaier, M.G. and Nanavaty, M.A. (2024) Transepithelial Photorefractive Keratectomy—Review. Vision, 8, Article 16. [Google Scholar] [CrossRef] [PubMed]
[18] Wannapanich, T., Kasetsuwan, N. and Reinprayoon, U. (2023) Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes. Clinical Ophthalmology, 17, 969-980. [Google Scholar] [CrossRef] [PubMed]
[19] Zhu, Q., Cao, X., Zhang, Y., Zhou, Y., Zhang, J., Zhang, X., et al. (2023) Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia—A Review. International Journal of Medical Sciences, 20, 1363-1376. [Google Scholar] [CrossRef] [PubMed]
[20] Jiang, Y., Zhu, Z., Tan, X., Kong, X., Zhong, H., Zhang, J., et al. (2022) Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial. Ophthalmology, 129, 509-519. [Google Scholar] [CrossRef] [PubMed]
[21] Amaral, D.C., Batista, S., dos Santos-Neto, E., Manso, J.E.F., Rodrigues, M.P.M., Monteiro, M.L.R., et al. (2024) Low-Level Red-Light Therapy for Myopia Control in Children: A Systematic Review and Meta-Analysis. Clinics, 79, Article ID: 100375. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, H., Yang, Y., Guo, J., Peng, J. and Zhao, P. (2023) Retinal Damage after Repeated Low-Level Red-Light Laser Exposure. JAMA Ophthalmology, 141, 693-695. [Google Scholar] [CrossRef] [PubMed]
[23] Janowski, M., Bulte, J.W.M., Handa, J.T., Rini, D. and Walczak, P. (2015) Concise Review: Using Stem Cells to Prevent the Progression of Myopia—A Concept. Stem Cells, 33, 2104-2113. [Google Scholar] [CrossRef] [PubMed]
[24] Garg, A., Yang, J., Lee, W. and Tsang, S. (2017) Stem Cell Therapies in Retinal Disorders. Cells, 6, Article 4. [Google Scholar] [CrossRef] [PubMed]
[25] Karouta, C., Kucharski, R., Hardy, K., Thomson, K., Maleszka, R., Morgan, I., et al. (2021) Transcriptome‐Based Insights into Gene Networks Controlling Myopia Prevention. The FASEB Journal, 35, e21846. [Google Scholar] [CrossRef] [PubMed]
[26] Ma, M., Zhang, Z., Du, E., Zheng, W., Gu, Q., Xu, X., et al. (2014) WNT Signaling in Form Deprivation Myopia of the Mice Retina. PLOS ONE, 9, e91086. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, Z., Xiu, Y., Qiu, F., Zhu, Z., Zong, R., Zhou, X., et al. (2021) Canonical WNT Signaling Drives Myopia Development and Can Be Pharmacologically Modulated. Investigative Opthalmology & Visual Science, 62, Article 21. [Google Scholar] [CrossRef] [PubMed]
[28] Cui, Z., Huang, Y., Chen, X., Chen, T., Hou, X., Yu, N., et al. (2023) Identification of miR-671-5p and Its Related Pathways as General Mechanisms of Both Form-Deprivation and Lens-Induced Myopia in Mice. Current Issues in Molecular Biology, 45, 2060-2072. [Google Scholar] [CrossRef] [PubMed]
[29] Hsiao, Y., Chang, W., Kuo, M., Lo, J., Lin, H., Yen, M., et al. (2019) Systematic Analysis of Transcriptomic Profile of the Effects of Low Dose Atropine Treatment on Scleral Fibroblasts Using Next-Generation Sequencing and Bioinformatics. International Journal of Medical Sciences, 16, 1652-1667. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, X., Ye, Y., Ge, Y., Qu, J., Liedberg, B., Zhang, Q., et al. (2024) Smart Contact Lenses for Healthcare Monitoring and Therapy. ACS Nano, 18, 6817-6844. [Google Scholar] [CrossRef] [PubMed]
[31] Lin, H., Long, E., Ding, X., Diao, H., Chen, Z., Liu, R., et al. (2018) Prediction of Myopia Development among Chinese School-Aged Children Using Refraction Data from Electronic Medical Records: A Retrospective, Multicentre Machine Learning Study. PLOS Medicine, 15, e1002674. [Google Scholar] [CrossRef] [PubMed]
[32] Wu, T., Chen, H., Jhou, M., Chen, Y., Chang, T. and Lu, C. (2020) Evaluating the Effect of Topical Atropine Use for Myopia Control on Intraocular Pressure by Using Machine Learning. Journal of Clinical Medicine, 10, Article 111. [Google Scholar] [CrossRef] [PubMed]

为你推荐